Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Insight Science & Technology is a leading pharmaceutical data and consulting firm based in Beijing, China, and is a subsidiary of the healthcare digital giant DXY (DingXiangYuan). The company is best known for its 'Insight Database,' a comprehensive intelligence platform used by pharmaceutical companies, investors, and researchers to track drug registration, clinical trials, and market dynamics in China. Beyond data services, Beijing Insight provides strategic consulting and real-world evidence (RWE) services, often acting as a sponsor or coordinator for clinical surveys and observational studies in therapeutic areas like oncology and hepatology. It serves as a critical bridge between clinical data and commercial strategy for the Chinese biopharmaceutical industry. The company's data is widely considered a gold standard for monitoring the Chinese regulatory landscape and competitive drug pipelines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Insight Science & Technology.